Alveolar Ridge Augmentation Using Various Bone Substitutes -A Web Form of Titanium Fibers Promotes Rapid Bone Development-

Similar documents
Guided Tissue and Bone Regeneration

Bone augmentation with maxgraft

More than bone regeneration. A total solution.

Innovative Range of Regenerative Solutions

Cerasorb M DENTAL. O:\Zulassung\Cerasorb Dental Kanada 2013\Texte\Cerasorb M Dental final IFU docx

Bone augmentation with biomaterials

Inion BioRestore. Bone Graft Substitute. Product Overview

A WIDE RANGE OF REGENERATIVE SOLUTIONS

botiss biomaterials bone & tissue regeneration collacone max Innovative composite matrix socket preservation form-fitting resorbable composite

THE NEW STANDARD OF EXCELLENCE IN BIOMATERIALS. Collagenated heterologous cortico-cancellous bone mix + TSV Gel GTO I N S P I R E D B Y N A T U R E

botiss dental bone & tissue regeneration biomaterials collacone max Innovative composite matrix socket preservation form-fitting resorbable composite

BONE AUGMENTATION AND GRAFTING

Biomaterials Line. MIS Corporation. All Rights Reserved.

BioVin Collagen Membrane

Regeneration Bone Grafting & Soft Tissue Management

BEGO BIOMATERIALS When the result counts

Pattern of bone resorption after extraction

Evaluation of different grafting materials in three-wall intra-bony defects around dental implants in beagle dogs

Sinus Augmentation Studies Methods and Definition

PRP Usage in Today's Implantology

chronos Bone Void Filler. Beta-Tricalcium Phosphate ( β-tcp) bone graft substitute.

Versatile grafting Solutions

Chemicals in Surgical Periodontal Therapy

INTERNATIONAL MEDICAL COLLEGE

OssiMend Bone Graft Matrix

Bone Grafting for Socket Preservation

BIOACTIVE SYNTHETIC GRAFT

easy-graft TM CRYSTAL

chronos Synthetic cancellous bone graft substitute ( -tricalcium phosphate) Remodels Replaced by bone in 6 18 months Easy to use

CLOSURE OF OROANTRAL COMMUNICATION WITH PLATELET-RICH FIBRIN

ALVEOLAR RIDGE AUGMENTATION UTILIZING PLATELET RICH FIBRIN IN COMBINATION WITH DEMINERALIZED FREEZE-DRIED BONE ALLOGRAFT A CASE REPORT

THE NEXT GENERATION OF REGENERATION

Clinical UM Guideline

B U I L D S T R O N G B O N E F A S T

THE NEXT FRONTIER OF BONE REGENERATION. where Technology meets Nature

PRO-STIM Injectable Inductive Graft TECHNICAL MONOGRAPH

Comparative Animal Study of OssiMend and Healos 13,14

Patient's Guide to Dental Implants. an investment for a lifelong smile

Department of Oral and Maxillofacial Surgery, Loma Linda University, Loma Linda, CA 92354, USA 2

Complications of postoperative swelling of the maxillary sinus membrane after sinus floor augmentation

Central Poorly Differentiated Adenocarcinoma of the Maxilla: Report of a Case

Maxillary sinus augmentation without any graft material- A case Report

The use of unidirectional porous β-tricarcium phosphate in surgery for calcaneal fractures: A report of four cases

A new approach with an in-situ self-hardening grafting material

Surgical Therapy. Tuesday, April 2, 13. Alessan"o Geminiani, DDS, MS

THE NEXT FRONTIER OF BONE REGENERATION. where Technology meets Nature

Study Cases: Ride Augmentation Bone by Grafting and PRP/Preparation for Dental Implants Placement

Horizontal bone augmentation by means of guided bone regeneration

THE NEXT FRONTIER OF BONE REGENERATION

Management of a complex case

FDBA(Freeze Dried Bone Allograft) SureOss Cortical Bone - Powder / Chip. OsteOss Cortical with Cancellous Bone - Powder / Chip

REFERENCES for PLATELET RICH PLASMA (PRP)

Effects of Calcium Phosphate Cement on the Peripheral Nerve Fibers

Product Information. MIS Corporation. All Rights Reserved.

THE NEXT FRONTIER OF BONE REGENERATION

NEW FIXATION STRATEGIES FOR OSTEOPOROTIC BONE

In the last decade of the 20 th century, special emphasis was put on an emerging field of science: Tissue engineering,which combines the state of the

In Vivo Heat-stimulus Triggered Osteogenesis

B&B DENTAL. implant company

Bone Tissue Biology & The Application of Synthetic Compounds for the Facilitation of Bone Tissue Healing

Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signalling pathway

Osseointegrated dental implant treatment generally

Case Study. Case # 1 Author: Dr. Suheil Boutros (USA) 2013 Zimmer Dental, Inc. All rights reserved. 6557, Rev. 03/13.

Regeneration Bone Grafting & Soft Tissue Management

Scientific & Clinical Evidence Jason membrane

synthetic CANCELLOUS BONE technical monograph Presented by Barbara Blum, Ph.D.

Calcium Phosphate Cement

Lawrence A. DiDomenico, DPM, FACFAS

B&B DENTAL. implant company MATERIAL FOR BONE REGENERATION

P105 Predictable Bone Grafting for Site Preparation for Implants and Prosthetics Workshop JAMES GRISDALE, DDS THURSDAY, FEBRUARY 26

REASONS TO USE R.T.R.

Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study

BCP SURFACE TREATMENT

Product Catalog. Dental Bone & Tissue Regeneration

In Vivo Evaluation of BioSphere Bioactive Bone Graft Putty: Improved Bone Formation

REGENERATIONTIME. A Case Report by. Ridge Augmentation and Delayed Implant Placement on an Upper Lateral Incisor

Bioactive Glass Biphasic β-tcp & HA Granules Alkylene Oxide Polymer Carrier. MEDLINEUNITE Bioactive Bone Graft

Clinical UM Guideline

Presentation of 17 different implant cases performed by Michael Tischler, DDS

BIOACTIVE BASICS. Bioactive materials elicit a controlled action and reaction in the physiological environment.

ctive Bone Bonding Bone Regeneration Osteostimulation*

Biomaterials for bone regeneration

The Original remains unique.

The Use of Freeze-Dried Bone Allograft as an Alternative to Autogenous Bone Graft in the Atrophic Maxilla: A 3-Year Clinical Follow-up

Pre op Failed endodontic treatment with sinus involvement.

Regeneration Bone Grafting & Soft Tissue Management

Extraction with Immediate Implant Placement and Ridge Preservation in the Posterior

Revisions for CDT 2016

The Essential Choice. With the Benefits of Biologic Predictability

Alloplastic Grafts - Beta-tricalcium phosphate

Bone modeling and remodeling How does a bone form without augmentation?

DRIVING THE FUTURE. About HOSPITAL INNOVATIONS. Strong commitment to healthcare innovation

Bone Engineering Arash Khojasteh, DMD, OMFS Assistant Professor of Oral and Maxillofacial Surgery Shahid Beheshti University of Medical Sciences

Contemporary Implant Dentistry

Treatment of Distal Radius Bone Defects with Injectable Calcium Sulphate Cement

Properties of GENESYS TM Biocomposite Material Compared to Pure Polylactide (PLA)

Micro-CT evaluation on osteoconductivity of DCPD-coated β-tcp granule using experimental rats

CRANIAL RECONSTRUCTION SOLUTIONS

The Essential Choice. With the Benefits of Biologic Predictability

ADVANCED BONE GRAFT SYSTEM OVERVIEW

Transcription:

Kobe J. Med. Sci., Vol. 53, No. 5, pp. 257-263 2007 Alveolar Ridge Augmentation Using Various Bone Substitutes -A Web Form of Titanium Fibers Promotes Rapid Bone Development- HIROSHI MASAGO 1, YASUYUKI SHIBUYA 1, SACHIKO MUNEMOTO 1, JUNICHIRO TAKEUCHI 1, MASAHIRO UMEDA 1, TAKAHIDE KOMORI 1, and YOSHINORI KUBOKI 2 1 Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, 2 Professor Emeritus, Hokkaido University Received 24 November 2006 /Accepted 15 March 2007 Key words: α-tricalcium phosphate (α-tcp), β-tricalcium phosphate (β-tcp), calcium phosphate cement (CPC), web form of titanium fibers (TW), alveolar ridge augmentation, Platelet-Rich-Plasma (PRP) Alveolar ridge augmentation with β-tricalcium phosphate (β-tcp) granules, calcium phosphate cement (CPC) powder and web form of titanium fibers (TW) added to Platelet-Rich-Plasma (PRP) was histologically observed for 5 months by the experiments using the maxilla of rabbits. As a result, TW was thus found to promote the rapid bone development within a period of less than 5 months, because TW had an appropriate gap between the titanium fibers for new bone progression. However, titanium fibers remained intact within the maxilla. The CPC powder was transformed into dense cement and also remained intact in the bone. These residual materials must be obstacles to perform the placement of dental implants. On the other hand, β-tcp granulations were gradually replaced by the new bone, but this process took about 5 months to be completed. Consequently, for an ideal alveolar bone substitute, there needs to be a suitable gap formation within the substitute, such as TW, and properties of total bone replacement, such as that seen in β-tcp granules. Alveolar bone defects of varying sizes occur as a result of oral surgery for jawbone cysts, tumors and facial traumas, and it is one of the most difficult tasks to regenerate new bone in the extensive defective area. In such cases, autogenous bone transplantation is clinically considered to be the most effective method. However, a surgical invasion to the donor site and the quantitative limitations of the extracted bone may sometimes cause clinical problems. If an autogenous bone transplant is too difficult to perform, other treatments such as distraction osteogenesis or fillings with various bone substitutes are thus generally performed. For bone regeneration, three conditions of proper scaffolds, efficient growth factors, and stem cells are needed (1). Bone substitutes are thought to be useful as proper scaffoldings. Lately, Platelet-Rich-Plasma (PRP) has been demonstrated to be a beneficial growth factor for bone regeneration (2, 3). Some bone marrow cells have been identified to have a potential similar to that of stem cells, thereby growing out from the surrounding bones via proper scaffoldings and thereafter differentiating into osteoblast cells (4). However, the method to precisely decide which bone substitutes is the most effective for the alveolar ridge Tel: 81-78-382-6213 Fax: 81-78-382-6229 e-mail: masago@ya2.so-net.ne.jp 257

H. MASAGO et al. augmentation for use in autogenous bone transplantation remains to be elucidated. Accordingly, in the present study, β-tricalcium phosphate (β-tcp) granules, calcium phosphate cement (CPC) powder and web form of titanium fibers (TW) were implanted into an artificial hole of the rabbit maxilla with PRP, and the findings were histologically assessed by light microscopy. Moreover, CPC powder mixed with PRP was examined to determine whether it could change into hydroxyapatite (HA) based on the findings of X-ray diffraction. MATERIALS AND METHODS 1. Experimental animals We used fifteen male New Zealand albino rabbits weighing 2.5 to 3 kg. We conducted all of the experiments according to the guidelines for animal experimentations established by Kobe University (Registration number: P-041213R). 2. Bone substitutes The three materials described below were used for bone supplements. β-tcp granules (Osferion R ), 500 1000 µm in diameter, were purchased from Olympus Biomaterial (Japan). One hundred mg weight of these granules were mixed with 160 µl of PRP just before filling. CPC powder (Biopex R ) to consist of α-tricalcium phosphate (75%), tetracalcium phosphate (18%), calcium hydrogen phosphate (5%), and HA (2%) was obtained from Mitsubishi Pharmaceutical Corporation (Japan). Five hundred mg of CPC powder were mixed with 160 µl of PRP directly before the experiments. A web form of titanium fibers was obtained from Hi-Lex Corporation (Japan). The fibers, coated with HA, are 80 µm in diameter and 500 g/m 2 in density, which consisted of a web measuring 4mm diameter and 1.3mm in thickness whose gap rate was 89%. Three web were mixed with 160 µl of PRP just before implantation. 3. Platelet-rich-plasma (PRP) Blood samples of 10 ml from the femoral vein of the rabbits added by EDTA-2K were centrifuged at 20 C for 15 minutes at 800 r.p.m (himac,cf7d/hitachi/japan), and the plasma components were further centrifuged for 15 minutes at 1300r.p.m. Thereafter, the lower stratum of 1 ml was used as PRP for this experiment. The platelet count level of this stratum was confirmed to be concentrated three- to ten-fold in comparison to the former blood. 4. Animal experiments and histological assessment The rabbit was put in a fixator and then was given under intravenous anesthesia (injected via the auricle cutaneous vein) with pentobarbital (Nembutal R ) (0.5 ml/kg). After giving local anesthesia to the upper gingival with 0.2 ml of 0.5% lidocaine (including a hundred thousand-fold epinephrine), the maxillary gum was dissected using approximately 1.5 cm incisions to expose the maxilla. The maxillary bone was scraped into a round shape (4mm in diameter) under rinsing water with a round bar of dental engine, and it was confirmed that the bone scraping did not intersect the nasal cavity. After stopping bleeding, each bone substitutes mixed with PRP as explained above was implanted into five rabbits (Fig.1a, b, and c), and then the gum was sutured with silk thread. Although no antibiotics were given after surgery, no infections were found. The rabbits, were all able to ingest solid food and water on the day after the surgery, and thereafter they were sacrificed by a megadose of pentobarbital on 1, 2 and 5 months after surgery. The upper jaw bone was removed and was soaked in Karnovsky fixing fluid. After fixing for over a week, the jaw bone was then made into decalcified specimens and was observed by light microscopy after being stained with toluidine blue. 258

ALVEOLAR AUGMENTATION BY BONE SUPPLEMENTS Fig.1 The site of the bone experiment. Filled various bone supplemental material mixed with PRP to bone defect (maxilla of rabbits). a; β-tricalcium phosphate (β-tcp) granules. b; calcium phosphate cement (CPC) powder. c; TW implantation 5. X-ray Diffraction of CPC Powder mixed with PRP Three lumps of CPC powder which hardened mixture with after being mixed with PRP were triturated with freeze-drying methods at 3, 7, 14, and 28 days after mixing, and then were analyzed by an X-ray diffractometer (RINT2400 model by Rigaku Corporation) with the measuring range was 2θ 20-40 o and the scanning speed was 4 o /min. The CPC powder alone and HA were also analyzed by X-ray diffraction as controls. RESULTS Histological assessment β-tcp granules mixed with PRP One month after filling, the β-tcp granules remained in various sizes. No new viable bone or soft tissue was thereafter found around the β-tcp granules (Fig.2a). Two months after filling, the absorption of β-tcp granules developed and some areas were replaced with new viable bone (Fig.2b). Five months after filling, the β-tcp granules were completely absorbed and replaced with the new viable bone in almost all of the treated areas (Fig.2c and 2d). CPC powder mixed with PRP On a month after filling, an aggregate of crystals of various sizes was observed (Fig.3a). No soft tissues could be found between the original bone and crystals of CPC, which meant to be in direct contact with each other. Two months later, regenerating bone was found to begin to develop into a gap of crystals (Fig.3b), however most of the crystallized substances still remained up until 5 months after surgery (Fig.3c and 3d). TW with PRP added One month after implantation, bone regeneration was found in a part of the space of TW (Fig.4a). Two months later a large amount of new bone was found to have developed into most of the space of TW (Fig.4b), and five months later new viable bone was observed throughout the entire space of TW (Fig.4c and 4d). X-ray Diffraction of CPC Powder mixed with PRP (Fig.5) By X-ray diffraction, the compound after three days from the mix of CPC powder with PRP showed almost the same waveforms of CPC powder alone, while also demonstrating the distinctive peaks of α-tricalcium phosphate (α-tcp) and slight peaks of HA. On the other hand, the α-tcp peaks became unclear as time passed and the HA peaks also gradually became higher. The HA peaks were clearer after 28 days than after 7 days. These findings were the same for all samples. 259

H. MASAGO et al. Fig.2 Light microscopical findings of the bone experiment with β-tcp (stained with toluidine blue). a; One month after filling( 40). The triturated substitutes remained as β-tcp granules of various sizes. No showing new viable bone or soft tissue in the space. b; Two months after filling ( 40) Absorption of β-tcp granules had developed. Showing some areas which were replaced with new viable bone. c and d; Five months after filling(c: 40, d: 100) β-tcp granules were completely absorbed and almost the entire area had been replaced with new viable bone. Osseous tissue (arrows) 260 Fig.3 Light microscopical findings of the bone with CPC (stained with toluidine blue). a; One month after filling ( 40). The triturated substances were observed consisting of an aggregate of crystals in various sizes in the space around them. b; Two months after filling ( 40). The regenerated bone begins to develop into a gap of crystals. c and d; Five months after filling (c: 40, d: 100). Showing new viable bone (arrowheads) in a gap of the crystal substances. Most of the crystal substances still remained.

ALVEOLAR AUGMENTATION BY BONE SUPPLEMENTS Fig.4 Light microscopical findings of the bone experiment with TW (stained with toluidine blue). a; One month after filling ( 40). Showing new viable bones in a part of the space of TW. b; Two months after filling ( 40). A large amount of bone appeared in the space of TW. c and d; Five months after filling (c: 40, d: 100). Showing new viable bone in the entire space of TW. Fig.5 X-ray diffraction of CPC powder mixed with PRP. A: Control (HA). B: On 28 days after mixing the CPC powder with PRP. C: On 14 days after mixing the CPC powder with PRP. D: On 7 days after mixing the CPC powder with PRP. E: On 3 days after mixing the CPC powder with PRP. F: CPC powder only. (arrows; HA peak, arrowheads; α-tcp peak) 261

H. MASAGO et al. DISCUSSION In this experiment, we used β-tcp granules, CPC powder and TW as bone substitutes, and examined any differences in bone regeneration with each bone substitutes. As for the site of the bone experiment, we used the alveolus where bone augmentation is frequently clinically required prior to performing the placement of dental implants. The PRP, used in this study as a growth factor, has been variously reported to be beneficial to bone regeneration (2,3,5,6). Platelets are cells derived from blood megakaryocytes of bone marrow and then they are divided into inactive cells and active cells. During the inactive periods, they demonstrate a disk appearance measuring 2-5μm in diameter, however they change their forms into a globular shape with one or several cytoplasmic processes and each platelet agglutinates during the active period. Moreover, after attaching to foreign substances, platelets release organ growth factors such as PDGF or TGF-β. PDGF, which is an organ growth factor released from the α-granules of platelets, and it is known to play a role in promoting wound healing and the proliferation of capillary vessels. TGF-β has also been reported to increase the number of osteoblast progenitor cells while also controlling the activation of osteoclasts (5,6,7,8). These growth factors are thus considered to contribute to bone regeneration. The ideal of bone substitutes are as follows; they should have biocompatibility, excellent osteoconductive properties and appropriate strength, and they should be able to form a suitable shape easily and to ultimately replace the bone completely within a short period (1). Our results showed the availability of the three materials in the biocompatibility and the osteoconductive properties, and these conclusions are also supported by other reports (9,10,11). As for the period until the bone substitutes, we concluded that β-tcp took 5 months, while CPC required more than 5 months, to have all spaces measuring 4 mm in diameter rearranged by the new bones. The reason why CPC showed a delayed bone replacement was that there was no space for new viable bone to progress because CPC developed into densely aggregated crystals. In addition, the crystals of CPC were considered to dissolve with difficulty from the findings of X-ray diffraction; namely, at 7 days after mixing the CPC powder with PRP, the compound was replaced with HA for the most part, and the purity of HA increased gradually after that. In fact, it is known that when CPC powder is mixed with the original hardening solution instead of PRP, CPC also changes into HA for a week, and the HA crystals within the bone have been reported to remain for more than 18 months in the clinical case (9). Consequently, to our disappointment, there was nothing to be identified in the present study about the effectiveness of PRP with CPC powder, because this compound also showed a delay in the bone replacement. Although TW was remaining intact in the maxilla, the new bone filled up the entire space among titanium fibers within less than 5 months, therefore TW promoted the most rapid bone development among the three materials. TW had a gap between each titanium fiber which averaged 200-400μm, which is considered to be appropriate for the new bone progression because the ideal space for the bone development is thought to be 300-400μm (12,13). On the other hand, according to the light microscopic findings, the spaces in β-tcp granules were 1.5 to 2.0 times larger than those of TW, which might be inappropriate for proper bone growth and thus might result in a delay in proper bone development. Bone substitutes must be able to make a suitable shape for the bone defect. β-tcp is in a granular form and CPC hardens gradually into cement, therefore they can fill in the damaged areas in any form. On the other hand, because TW has a web form, it needs to be cut and bent to fit into the damaged area beforehand, and this procedure is therefore considered to be a disadvantage. 262

ALVEOLAR AUGMENTATION BY BONE SUPPLEMENTS Consequently, it is necessary to exploit other new materials to reliably replace bones. ACKNOWLEDGEMENTS We thank Mr. Masahiro Hirano of Mitsubishi Materials Corporation that cooperated in X-ray diffraction. REFERENCES 1. Yoshikawa, H., Myoui,A. 2005. Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs; 8:131-136. 2. Fennis,J.P.M., Stoelinga,P.J.W., Jansen,J.A. 2004. Mandibular reconstruction: a histological and histomorphometric study on the use of autogenous scaffolds, particulate cortico-cancellous bone grafts and platelet rich plasma in goats. Int.J.Oral Maxillofac.Surg.; 33:48-55. 3. Arpornmaeklong,P., Kochel,M. 2004. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. Int.J.Oral Maxillofac.Surg.; 33:60-70. 4. Pittenger,M.F., Mackay,A.M., Beck,S.C. 1999. Multilineage potential of adult human mesenchymal cells. Science; 284:143-147. 5. B.-H.Choi,C.-J.Im. 2004. Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. I.nt.J.Oral Maxillofac.Surg.; 33:56-59. 6. Marx,R.E, Gard,A.K. 1999. Bone graft physiology with use of platelet-rich plasma and hyperbaric oxygen. In:Gensen OT(ed). The Sinus Bone Graft.Chicago:Quintessence,: 183-190. 7. Mohan,S.,Baylink,D. Bone growth factors. Clin Orthop Rel Res 1991; 263:30-43. 8. Pierce,G., Tarpley,J., Yanagihara,D., Deuer,T. 1992. PDGF-ββ, TGF-β1 and basic FGF in dermal wound healing: Neovessel and matrix formation and cessation of repair. Am J Pathol; 140: 1375-1388. 9. Kurashina,K., Kurita,H. 1997. In vivo study of a calcium phosphate cement consisting of α-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide. Biomaterials; 18: 147-151. 10. X.Frank Walboomers,John A.Jansen. 2005. Bone tissue induction, using a COLLOSS-filled titanium fiber mesh-scaffolding material. Biomaterials; 26: 4779-4785. 11. Yamamoto,H. 1997. Experimental studies for clinical application of calcium phosphate cement. J. Aichi Med. Univ. Assoc.; 25(2): 219-229. 12. Kuboki,Y., Takita,H., Mizuno,M., and Fujisawa,R. 2001. Geometry of Artificial Extracellular Matrices:a New Paradigm from Dental Tissue Engineering. Dentistry in Japan; 37: 42-50. 13. Kuboki,Y., Qiming,Jin,,Takita,H. 2001. Geometry of Carriers Controlling Phenotypic Expression in BMP-Induced Osteogenesis and Chondrogenesis. J. Bone Joint Surg.; 83-A, S1-105-115. 263